Silo Pharma Advances Clinical Study Analyzing Effects Of Psilocybin On Inflammation
Parkinson's disease, bipolar disorder, and chronic pain targeted in study
Study aims to support psilocybin as a potential therapeutic for inflammatory disorders
DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.64) by 6.25 percent. This is a 36 percent decrease over losses of $(0.50) per share from the same
Imagine a program where college students learn financial skills and teach their peers knowledge for financial success. The SFE&PD Student Ambassador Program is doing precisely this at Howard University, University of the District of Columbia (UDC), and Medgar Evers College in partnership with Carver Federal Savings Bank ("Carver").